— Know what they know.
Not Investment Advice

SOLV NYSE

Solventum Corporation
1W: +3.1% 1M: +11.0% 3M: +5.2% YTD: -2.9% 1Y: +2.7%
$76.83
+0.08 (+0.10%)
 
Weekly Expected Move ±3.5%
$69 $72 $74 $77 $79
NYSE · Healthcare · Medical - Care Facilities · Alpha Radar Strong Buy · Power 77 · $13.3B mcap · 147M float · 0.974% daily turnover · Short 66% of daily vol

Cash Flow Trends

Operating Cash Flow
$369M -68.9% ▼
5Y CAGR: -28.9%
Capital Expenditures
$379M +0.3% ▲
5Y CAGR: +6.9%
Free Cash Flow
-$10M -101.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$116M -79.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$1.5B$1.3B$1.3B$479M$1.6B
Depreciation & Amort.$597M$578M$561M$555M$489M
Stock-Based Comp.$38M$37M$39M$112M$161M
Change in Working Capital$67M-$202M$126M$160M-$119M
Other Non-Cash Items$74M$64M-$15M$34M-$1.6B
Operating Cash Flow$2.2B$1.7B$1.9B$1.2B$369M
— Investing Activities —
Capital Expenditures-$277M-$251M-$290M-$380M-$379M
Acquisitions (Net)$0$0$60M$0-$696M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$1M-$2M$0$0$3.9B
Investing Cash Flow-$278M-$253M-$230M-$380M$2.8B
— Financing Activities —
Net Debt Issuance$0$0$0$8.0B-$3.1B
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$2.0B-$1.5B-$1.6B-$8.2B$13M
Financing Cash Flow-$2.0B-$1.5B-$1.6B-$240M-$3.1B
Net Change in Cash-$33M-$30M$133M$568M$116M
Cash End of Period$91M$61M$194M$762M$878M
Free Cash Flow$1.9B$1.4B$1.6B$805M-$10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms